Dyslipidaemia and diabetes - use of fenofibrate in diabetic dyslipidaemia treatment

Abstract

Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease (2-4 times higher compared to non-diabetic population).

Keywords

• dyslipidaemia
• type 2 diabetes mellitus
• cardiovascular disease
• fenofibrate
• microvascular disease
• fenofibrate
• microvascular complications of diabetes